Thisis about empowering patients and giving them tools and information so that they can make better, more informed decisions about their own health care…t's important to have this level of transparency and accountability. It creates even more confidence in our health-care system.
When these transfers of value take place they can have unintended consequences…his isn’t suggesting at all the transfers are inappropriate. It’s important that the value and nature of those transfers . . . be made transparent.
I think there’s been a big blind spot in our health system for a long time. This helps address that… “It allows us to gain insight into some of the interactions between the pharmaceutical industry and health-care professionals that we previously had no idea about.Dr. Boozary hopes that Ontario’s move will help spur action both in other provinces and federally. Dr. Hoskins echoes these sentiments, and has stated that ideally Ontario’s action on this will “inspire” his counterparts. We will continue to follow developments in this proposed legislation and will provide updates as they become available. At Wise Health Law, we provide exceptional guidance on health law matters to regulated health professionals, regulated health professional associations, public hospitals, and other health-care organizations across the province. We monitor trends and developments in health care, medicine, and health law so that we can provide outstanding and forward-thinking legal advice to each of our clients. Contact us online, or at 416-915-4234 for a consultation.
The Chief Medical Officer of Health for Ontario has issued an updated Directive #2 (dated May 26, 2020) for Regulated Health Professionals in the province.
Pursuant to the updated Directive #2, all deferred non-essential and elective services by health care providers may be gradually restarted – subject to the rest of the requirements set out in the Directive.
The updated Directive #2 does not provide particularly detailed guidance to health professionals on how to proceed, likely because it applies to such a broad spectrum of health care and health professionals. It does, however, provide some principles to assist health care providers in making decisions as we enter this transitional period.
In addition to the mask and hand sanitizer shortages, Ontario’s response to COVID-19 highlights the need for more frontline health care workers. Each regulated health profession’s college responded differently, and we have discussed some of those changes in other posts to keep you apprised.
Today, we focus on the College of Physicians and Surgeons of Ontario (CPSO), who set out to increase the number of available and licenced physicians out on the frontlines through certificates of registration that authorize supervised practice of short duration. The temporary licences authorize practice for 30 days.
Undoubtedly, COVID-19 has affected how health professionals practice. Pharmacists across the country are not only experiencing changes in how they practice (for example, accepting emailed prescriptions, where appropriate) but the scope of their practice as well. The latter change is not permanent, although the disruptions in practice may be felt long after the COVID-19 emergency subsides.
On March 19, 2020, Health Canada issued a short-term section 56(1) exemption under the Controlled Drugs and Substances Act (CDSA) that would authorize pharmacists to prescribe, sell, or provide controlled substances in limited circumstances, or transfer prescriptions for controlled substances (the CDSA Exemption).
